Recent Projects and Leadership Roles
We are honored to have been entrusted with vital leadership roles that have had significant impact on the boards and businesses they serve, with a representative list below.
FEATURED PLACEMENTS
Cardiff Oncology
Chief Medical Officer
Engrail Therapeutics
EVP, Clinical Development and Medical Affairs
OmniAb
Independent Director
Areteia Therapeutics/Validae Health
VP, Clinical Operations
UNITY BIOTECHNOLOGY
VP, Chief Medical Officer
AVIDITY BIOSCIENCES
Chief Technology Officer
| Cardiff Oncology | Independent Director (2) |
| Carina Biotech | Independent Director (2) |
| Fate Therapeutics | Independent Director |
| Histogen | Independent Director (2) |
| Illumina | Independent Director (3) Ethics Advisory Board |
| Mammogen | Independent Director |
| Pliant Therapeutics | Independent Director (2) |
| SioGene Therapies | Independent Director |
| Vaxxinity | Independent Director |
| Alexion | Chief Medical Officer |
| Alovant | President and Chief Operating Officer |
| Ascensia | Chief Medical Officer |
| Aviwell | Chief Executive Officer & Director |
| Bexion Pharmaceuticals | Chief Executive Officer & Director Chief Financial Officer |
| BioLA | Chief Executive Officer |
| Brickell Biotech | Chief Medical Officer |
| Cardiff Oncology | Chief Scientific Officer |
| Cellectis | Chief Medical Officer |
| Cellics | Chief Executive Officer & Director |
| Confidential | Chief Financial Officer |
| Corsair | Chief Executive Officer |
| Critical Path Institute | Chief Executive Officer & Director |
| Dermavant Sciences | Chief Scientific Officer |
| Engrail | CSO and SVP of Development, Chief Financial Officer |
| Exciva | Chief Executive Officer & Director |
| Fate Therapeutics | Chief Medical Officer |
| Gallant | Chief Executive Officer & Director |
| Glenmark | Chief Commercial Officer |
| Halozyme | Chief Information Officer |
| Imagion | Chief Development Officer |
| Inivata, Inc. | Chief Medical Officer |
| LabCentral | Chief People Officer |
| Lineage Cell Therapeutics | Chief Executive Officer & Director |
| Mammogen | Chief Executive Officer & Director |
| Neuraptive | Chief Operating Officer and EVP, Head of R&D |
| New Rhein | Managing Partner & Chief Medical Officer |
| Onchilles | Chief Scientific Officer |
| Pierian | Chief Executive Officer & Director |
| Poseida | President, Gene Therapy President, Cell Therapy |
| Sanofi | Chief Patient Officer |
| Symbio Pharmaceuticals | Chief Executive Officer |
| United Bomedical | EVP, Research & Development |
| United Neuroscience | Chief Scientific Officer |
| Valavant | Chief Executive Officer & Director |
| 3T Biosciences | Head of Finance |
| Accent Therapeutics | Head of Biology |
| Adaptimmune | VP, Clinical Development |
| Advaxis | VP, Medical |
| Alexion | SVP, Medical Affairs Country Leader VP, Clinical Development Neurology,br> VP, Quality Operations |
| Almatica | VP, Regulatory Affairs |
| Amicus | SVP, Clinical Research, Gene Therapy Global Head of Medical Affairs |
| Ascensia | Global Head, Clinical Development & Operations |
| Atyr | VP, Regulatory Affairs |
| Bayer Healthcare | Therapeutic Head, Cardiovascular Head of Development Center, Skincare Country Head France, BAH Pricing Market Access EU |
| Becton Dickinson | VP, Medical Affairs (4) |
| Beigene | SVP, Global Head Business Development VP, Alliance Project VP, Global Clinical Operations VP, Head of Europe Medical Affairs,br> VP, Head of Late Stage Development |
| Blueprint Medicines | VP, Biology VP, Translational Medicine |
| Cardiff Oncology Inc. | SVP, Regulatory Affairs |
| Cellectis | SVP, Regulatory Affairs |
| Clovis | VP, Safety & Pharmacovigilance |
| Embecta (subsidiary of BD) | Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer |
| EyePoint Pharmaceuticals | Senior VP, Program Leadership |
| Fate Therapeutics | SVP, Corporate Development SVP, Technical Operations VP, Clinical Development (3) VP, Solid Tumor Biology |
| Glenmark | VP, Market Access |
| Halozyme | VP, Chief Information Officer |
| Humacyte Inc. | VP, Scientific & Medical Communications |
| Idorsia | Clinical Lead – Neurology |
| Insmed | SVP, Head of Clinical Development |
| Intellectual Ventures | Commercial Lead, Medical Technologies |
| Intercept | VP, Regulatory Affairs, R&D |
| Jasper Therapeutics | VP, Clinical Operations |
| Johnson & Johnson | VP, Biologics Discovery Head, J&J Innovation West NA, Australia & New Zealand |
| LabCentral | Executive Director, Ignite |
| Myovant | SVP, Pharma. Operations and Development |
| Nutrinia | VP, Regulatory Affairs |
| Pfizer | VP, Development Head Immuno-Oncology Medicine Team Lead |
| Pharma Essentia | Global Head of Pharmacovigilance |
| Regeneron | Global Program Head – Oncology VP, Strategic Program Direction TA Head, Oncology VP, Global Program Head Immunology Strategic Program Director, CV/META Strategic Program Heads (2) |
| Regulus | VP, Preclinical Development |
| Sanofi | Head of Bioprocesses |
| Symbio Pharmaceuticals | SVP R&D and Global Chief Medical Officer |
| Talis BioMedical | VP, Assay Development |
| Urovant | VP, Manufacturing |
| VP, Regulatory Affairs & Quality Assurance | VP, Manufacturing |
| Urovant | VP, Manufacturing |
| Zymeworks | SVP, Research |
C-SUITE
| Alexion | Chief Medical Officer |
| Alovant | President and Chief Operating Officer |
| Ascensia | Chief Medical Officer |
| Avidity | Chief Technical Officer |
| Aviwell | Chief Executive Officer & Director |
| Bexion Pharmaceuticals | Chief Executive Officer & Director Chief Financial Officer EVP & Chief Medical Officer |
| BioLA | Chief Executive Officer |
| Brickell Biotech | Chief Medical Officer |
| Cardiff Oncology | Chief Medical Officer Chief Scientific Officer |
| Cellectis | Chief Medical Officer |
| Cellics | Chief Executive Officer & Director |
| Confidential | Chief Financial Officer |
| Corsair | Chief Executive Officer |
| Critical Path Institute | Chief Executive Officer & Director |
| Dermavant Sciences | Chief Scientific Officer |
| Engrail | CSO and SVP of Development Chief Financial Officer |
| Exciva | Chief Executive Officer & Director |
| EyePoint Pharmaceuticals | Chief Medical Officer |
| Fate Therapeutics | Chief Medical Officer |
| Gallant | Chief Executive Officer & Director |
| Glenmark | Chief Commercial Officer |
| Halozyme | Chief Information Officer Chief Medical Officer Chief Operating Officer |
| Imagion | Chief Development Officer |
| Inivata, Inc. | Chief Medical Officer |
| Kaléo | Chief Development Officer |
| LabCentral | Chief People Officer |
| Lineage Cell Therapeutics | Chief Executive Officer & Director |
| Mammogen | Chief Executive Officer & Director |
| Neuraptive | Chief Operating Officer and EVP, Head of R&D |
| New Rhein | Managing Partner & Chief Medical Officer |
| Onchilles | Chief Scientific Officer |
| Pierian | Chief Executive Officer & Director |
| Poseida | President, Gene Therapy President, Cell Therapy |
| Sanofi | Chief Patient Officer |
| Symbio Pharmaceuticals | Chief Executive Officer |
| United Bomedical | EVP, Research & Development |
| United Neuroscience | Chief Scientific Officer |
| UNITY Biotechnology | Chief Medical Officer |
| Valavant | Chief Executive Officer & Director |
BOARD & ADVISORY BOARD
| Avidity Biosciences | Independent Director |
| Cardiff Oncology | Independent Director (2) |
| Carina Biotech | Independent Director (2) |
| Fate Therapeutics | Independent Director |
| Histogen | Independent Director (2) |
| Illumina | Independent Director (3) Ethics Advisory Board |
| Mammogen | Independent Director |
| OmniAb | Independent Director |
| Pliant Therapeutics | Independent Director (2) |
| SioGene Therapies | Independent Director |
| Vaxxinity | Independent Director |
EXECUTIVE LEADERSHIP
| 3T Biosciences | Head of Finance |
| Accent Therapeutics | Head of Biology |
| Adaptimmune | VP, Clinical Development |
| Advaxis | VP, Medical |
| Alexion | SVP, Medical Affairs Country Leader VP, Clinical Development Neurology,br> VP, Quality Operations |
| Almatica | VP, Regulatory Affairs |
| Amicus | SVP, Clinical Research, Gene Therapy Global Head of Medical Affairs |
| Areteia Therapeutics/Validae Health | VP, Clinical Operations |
| Argenx | Vice President Global Clinical Strategy Lead |
| Ascensia | Global Head, Clinical Development & Operations |
| Atyr | VP, Regulatory Affairs |
| Avidity | SVP, Global Program Head |
| Bayer Healthcare | Therapeutic Head, Cardiovascular Head of Development Center, Skincare Country Head France, BAH Pricing Market Access EU |
| Becton Dickinson | VP, Medical Affairs (4) |
| Beigene | SVP, Global Head Business Development VP, Alliance Project VP, Global Clinical Operations VP, Head of Europe Medical Affairs,br> VP, Head of Late Stage Development |
| Blueprint Medicines | VP, Biology VP, Translational Medicine |
| Cardiff Oncology Inc. | SVP, Regulatory Affairs |
| Cargo Therapeutics | VP, Regulatory Affairs |
| Cellectis | SVP, Regulatory Affairs |
| Clovis | VP, Safety & Pharmacovigilance |
| Embecta | Global Head Medical, Clinical and Scientific Affairs & Chief Medical Officer |
| Engrail | EVP, Clinical Development and Medical Affairs Sr. Director, Clinical Operations (2) VP, Head of Quality |
| Excellos | Vice President, Business Development |
| Exelixis | SVP, Business Development VP, Program Leadership Executive Program Leadership Director |
| EyePoint Pharmaceuticals | Senior VP, Program Leadership |
| Fate Therapeutics | SVP, Corporate Development SVP, Technical Operations VP, Clinical Development (3) VP, Solid Tumor Biology |
| Glenmark | VP, Market Access |
| Halozyme | VP, Business Development |
| Humacyte Inc. | VP, Scientific & Medical Communications |
| Idorsia | Clinical Lead – Neurology |
| Insmed | SVP, Head of Clinical Development |
| Intellectual Ventures | Commercial Lead, Medical Technologies |
| Intercept | VP, Regulatory Affairs, R&D |
| Jasper Therapeutics | VP, Clinical Operations |
| Johnson & Johnson | VP, Biologics Discovery Head, J&J Innovation West NA, Australia & New Zealand |
| Kojin | SVP, Discovery Biology |
| LabCentral | Executive Director, Ignite |
| Metsera | SVP, Clinical Pharmacology SVP Pharmacovigilance VP Finance & Controller Sr Director Scientific & Medical Writing VP Scientific & Medical Writing SVP Biostatistics Sr Director Medical Writing VP Safety & Toxicology SVP Strategic Mfg SVP Clinical Pharmacology SVP, Head of Global Regulatory Affairs |
| Myovant | SVP, Pharma. Operations and Development |
| Neurvati Neurosciences and GRIN Therapeutics | Executive Director of Medical Affairs |
| Nutrinia | Senior Vice President, Development Operations |
| Onchilles | VP, Regulatory Affairs |
| Pfizer | VP, Development Head Immuno-Oncology Medicine Team Lead |
| Pharma Essentia | Global Head of Pharmacovigilance |
| Regeneron | Global Program Head – Oncology VP, Strategic Program Direction TA Head, Oncology VP, Global Program Head Immunology Strategic Program Director, CV/META Strategic Program Heads (2) |
| Regulus | VP, Preclinical Development |
| Sanofi | Head of Bioprocesses |
| Symbio Pharmaceuticals | SVP R&D and Global Chief Medical Officer VP, Regulatory Affairs |
| Talis BioMedical | VP, Assay Development |
| Tarsus | SVP, Development |
| Urovant | VP, Manufacturing |
| Vanotech | Head, Business Development |
| Urovant | VP, Manufacturing |
| Zymeworks | SVP, Research |
We make life-changing placements so our clients can change lives!®